Impact of Electronic Cigarettes on Various Organ Systems

References

1. 1.↵
   1. Hon L

   1. Hon L

   , Inventor; Hon L, assignee. Flameless electronic atomizing cigarette. US patent 20060196518 A1. Sep 7, 2006.
2. 2.↵
   1. Marynak KL,
   2. Gammon DG,
   3. King BA,
   4. et al

   . National and state trends in sales of cigarettes and e-cigarettes, U.S., 2011-2015. Am J Prev Med 2017;53(1):96–101.

   OpenUrlPubMed
3. 3.↵
   1. Kasza KA,
   2. Ambrose BK,
   3. Conway KP,
   4. et al

   . Tobacco-product use by adults and youths in the United States in 2013 and 2014. N Engl J Med 2017;376(4):342–353.

   OpenUrlPubMed
4. 4.↵
   1. Jamal A,
   2. Gentzke A,
   3. Hu SS,
   4. et al

   . Tobacco use among middle and high school students: United States, 2011-2016. MMWR Morb Mortal Wkly Rep 2017(65):361–367.
5. 5.↵
   1. Etter JF,
   2. Bullen C

   . Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 2011;106(11):2017–2028.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Choi K,
   2. Forster JL

   . Beliefs and experimentation with electronic cigarettes: a prospective analysis among young adults. Am J Prev Med 2014;46(2):175–178.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Huang J,
   2. Kornfield R,
   3. Emery SL

   . 100 Million views of electronic cigarette YouTube Videos and counting: quantification, content evaluation, and engagement levels of videos. J Med Internet Res 2016;18(3):e67.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. McRobbie H,
   2. Phillips A,
   3. Goniewicz ML,
   4. et al

   . Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Cancer Prev Res (Phila) 2015;8(9):873–878.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Ray R,
   2. Schnoll RA,
   3. Lerman C

   . Nicotine dependence: biology, behavior, and treatment. Annu Rev Med 2009;60:247–260.

   OpenUrlPubMed
10. 10.↵
    1. Ambrose BK,
    2. Day HR,
    3. Rostron B,
    4. et al

    . Flavored tobacco product use among US youth aged 12-17 years, 2013-2014. JAMA 2015;314(17):1871–1873.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. McMillen RC,
    2. Gottlieb MA,
    3. Shaefer RM,
    4. Winickoff JP,
    5. Klein JD

    . Trends in electronic cigarette use among U.S. adults: use is increasing in both smokers and nonsmokers. Nicotine Tob Res 2015;17(10):1195–1202.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Leventhal AM,
    2. Strong DR,
    3. Kirkpatrick MG,
    4. et al

    . Association of electronic cigarette use with initiation of combustible tobacco product smoking in early adolescence. JAMA 2015;314(7):700–707.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Brownson EG,
    2. Thompson CM,
    3. Goldsberry S,
    4. et al

    . Explosion injuries from e-cigarettes. N Engl J Med 2016;375(14):1400–1402.

    OpenUrl
14. 14.↵
    1. McKenna LA Jr.

    . Electronic cigarette fires and explosions in the United States 2009-2016. Emmitsburg, MD: US Fire Administration; 2017. Available at: https://www.hsdl.org/?view&did=804891. Accessed September 14, 2018.
15. 15.↵
    Toxicology Data Network [database online]. Propylene glycol. CASRN: 57-55-6. Bethesda, MD: US National Library of Medicine; 2017. Available at: https://toxnet.nlm.nih.gov. Accessed May 4, 2017.
16. 16.↵
    1. Laino T,
    2. Tuma C,
    3. Moor P,
    4. Martin E,
    5. Stolz S,
    6. Curioni A

    . Mechanisms of propylene glycol and triacetin pyrolysis. J Phys Chem A 2012;116(18):4602–4609.

    OpenUrlCrossRefPubMed
17. 17.↵
    Toxicology Data Network [database online]. 1,2-Propylene oxide. CASRN: 75-56-9. Bethesda, MD: US National Library of Medicine; 2017. Available at: https://toxnet.nlm.nih.gov/. Accessed April 20, 2017.
18. 18.↵
    Toxicology Data Network [database online]. Glycerin: CASRN 56-81-5. Bethesda, MD: US National Library of Medicine; 2017. Available at: https://toxnet.nlm.nih.gov/. Accessed April 20, 2017.
19. 19.↵
    Toxicology Data Network [database online]. Acrolein. CASRN: 107-02-8. Betheda, MD: US National Library of Medicine; 2017. Available at: https://toxnet.nlm.nih.gov/. Accessed April 20, 2017.
20. 20.↵
    1. Lerner CA,
    2. Sundar IK,
    3. Yao H,
    4. et al

    . Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One 2015;10(2):e0116732.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Brieger K,
    2. Schiavone S,
    3. Miller FJ Jr.,
    4. Krause KH

    . Reactive oxygen species: from health to disease. Swiss Med Wkly 2012;142:w13659.

    OpenUrlPubMed
22. 22.↵
    1. Etter JF

    . Throat hit in users of the electronic cigarette: an exploratory study. Psychol Addict Behav 2016;30(1):93–100.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Varlet V,
    2. Farsalinos K,
    3. Augsburger M,
    4. Thomas A,
    5. Etter JF

    . Toxicity assessment of refill liquids for electronic cigarettes. Int J Environ Res Public Health 2015;12(5):4796–4815.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Valentine GW,
    2. Jatlow PI,
    3. Coffman M,
    4. Nadim H,
    5. Gueorguieva R,
    6. Sofuoglu M

    . The effects of alcohol-containing e-cigarettes on young adult smokers. Drug Alcohol Depend 2016;159:272–276.

    OpenUrl
25. 25.↵
    1. Cheng T

    . Chemical evaluation of electronic cigarettes. Tob Control. 2014;23(Suppl 2):ii11–ii17.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    United States Environmental Protection Agency. Volatile organic compounds' impact on indoor air quality. Available at: https://www.epa.gov/indoor-air-quality-iaq/volatile-organic-compounds-impact-indoor-air-quality. Accessed July 3, 2017.
27. 27.↵
    Agency for Toxic Substances and Disease Registry. Toxicological Profile for Polycyclic Aromatic Hydrocarbons. Atlanta: U.S. Department of Health and Human Services; 1995.
28. 28.↵
    1. Goniewicz ML,
    2. Knysak J,
    3. Gawron M,
    4. et al

    . Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014;23(2):133–139.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Williams M,
    2. Bozhilov K,
    3. Ghai S,
    4. Talbot P

    . Elements including metals in the atomizer and aerosol of disposable electronic cigarettes and electronic hookahs. PLoS One 2017;12(4):e0175430.

    OpenUrl
30. 30.↵
    1. Fernandez E,
    2. Ballbe M,
    3. Sureda X,
    4. Fu M,
    5. Salto E,
    6. Martinez-Sanchez JM

    . Particulate matter from electronic cigarettes and conventional cigarettes: a systematic review and observational study. Curr Environ Health Rep 2015;2(4):423–429.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Lee MS,
    2. LeBouf RF,
    3. Son YS,
    4. Koutrakis P,
    5. Christiani DC

    . Nicotine, aerosol particles, carbonyls and volatile organic compounds in tobacco- and menthol-flavored e-cigarettes. Environ Health 2017;16(1):42.

    OpenUrl
32. 32.↵
    1. Schripp T,
    2. Markewitz D,
    3. Uhde E,
    4. Salthammer T

    . Does e-cigarette consumption cause passive vaping? Indoor Air 2013;23(1):25–31.

    OpenUrlCrossRefPubMedWeb of Science
33. 33.↵
    1. McAuley TR,
    2. Hopke PK,
    3. Zhao J,
    4. Babaian S

    . Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal Toxicol 2012;24(12):850–857.

    OpenUrlCrossRefPubMed
34. 34.↵
    1. Schober W,
    2. Szendrei K,
    3. Matzen W,
    4. et al

    . Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. Int J Hyg Environ Health 2014;217(6):628–637.

    OpenUrlCrossRefPubMed
35. 35.↵
    National Institute for Occupational Safety and Health. Flavorings-Related Lung Disease. Available at: https://www.cdc.gov/niosh/topics/flavorings/exposure.html. Accessed July 1, 2017.
36. 36.↵
    1. Barrington-Trimis JL,
    2. Samet JM,
    3. McConnell R

    . Flavorings in electronic cigarettes: an unrecognized respiratory health hazard? JAMA 2014;312(23):2493–2494.

    OpenUrlCrossRefPubMedWeb of Science
37. 37.↵
    1. Gerloff J,
    2. Sundar IK,
    3. Freter R,
    4. et al

    . Inflammatory response and barrier dysfunction by different e-cigarette flavoring chemicals identified by gas chromatography-mass spectrometry in e-liquids and e-vapors on human lung epithelial cells and fibroblasts. Appl In Vitro Toxicol 2017;3(1):28–40.

    OpenUrlCrossRefPubMed
38. 38.↵
    1. Goniewicz ML,
    2. Kuma T,
    3. Gawron M,
    4. Knysak J,
    5. Kosmider L

    . Nicotine levels in electronic cigarettes. Nicotine Tob Res 2013;15(1):158–166.

    OpenUrlCrossRefPubMedWeb of Science
39. 39.↵
    1. Talih S,
    2. Balhas Z,
    3. Eissenberg T,
    4. et al

    . Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield: measurements and model predictions. Nicotine Tob Res 2015;17(2):150–157.

    OpenUrlCrossRefPubMed
40. 40.↵
    1. Ramoa CP,
    2. Hiler MM,
    3. Spindle TR,
    4. et al

    . Electronic cigarette nicotine delivery can exceed that of combustible cigarettes: a preliminary report. Tob Control 2016;25(e1):e6–e9.

    OpenUrlAbstract/FREE Full Text
41. 41.↵
    1. Farsalinos KE,
    2. Spyrou A,
    3. Tsimopoulou K,
    4. Stefopoulos C,
    5. Romagna G,
    6. Voudris V

    . Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep 2014;4:4133.

    OpenUrlCrossRefPubMed
42. 42.↵
    1. Dwyer JB,
    2. McQuown SC,
    3. Leslie FM

    . The dynamic effects of nicotine on the developing brain. Pharmacol Ther 2009;122(2):125–139.

    OpenUrlCrossRefPubMedWeb of Science
43. 43.↵
    1. Farsalinos KE,
    2. Romagna G,
    3. Allifranchini E,
    4. et al

    . Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health 2013;10(10):5146–5162.

    OpenUrlCrossRefPubMed
44. 44.↵
    1. Palpant NJ,
    2. Hofsteen P,
    3. Pabon L,
    4. Reinecke H,
    5. Murry CE

    . Cardiac development in zebrafish and human embryonic stem cells is inhibited by exposure to tobacco cigarettes and e-cigarettes. PLoS One 2015;10(5):e0126259.

    OpenUrlCrossRefPubMed
45. 45.↵
    1. Farsalinos KE,
    2. Tsiapras D,
    3. Kyrzopoulos S,
    4. Savvopoulou M,
    5. Voudris V

    . Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovasc Disord 2014;14:78.

    OpenUrlPubMed
46. 46.↵
    1. Antoniewicz L,
    2. Bosson JA,
    3. Kuhl J,
    4. et al

    . Electronic cigarettes increase endothelial progenitor cells in the blood of healthy volunteers. Atherosclerosis 2016;255:179–185.

    OpenUrlCrossRefPubMed
47. 47.↵
    1. Carnevale R,
    2. Sciarretta S,
    3. Violi F,
    4. et al

    . Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function. Chest 2016;150(3):606–612.

    OpenUrlCrossRefPubMed
48. 48.↵
    1. McGrath-Morrow SA,
    2. Hayashi M,
    3. Aherrera A,
    4. et al

    . The effects of electronic cigarette emissions on systemic cotinine levels, weight and postnatal lung growth in neonatal mice. PLoS One. 2015;10(2):e0118344.

    OpenUrlCrossRefPubMed
49. 49.↵
    1. Cervellati F,
    2. Muresan XM,
    3. Sticozzi C,
    4. et al

    . Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicol In Vitro 2014;28(5):999–1005.

    OpenUrlCrossRefPubMed
50. 50.↵
    1. Hwang JH,
    2. Lyes M,
    3. Sladewski K,
    4. et al

    . Electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria. J Mol Med (Berl) 2016;94(6):667–679.

    OpenUrlCrossRefPubMed
51. 51.↵
    1. Scheffler S,
    2. Dieken H,
    3. Krischenowski O,
    4. Forster C,
    5. Branscheid D,
    6. Aufderheide M

    . Evaluation of e-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Int J Environ Res Public Health 2015;12(4):3915–3925.

    OpenUrlCrossRefPubMed
52. 52.↵
    1. Misra M,
    2. Leverette RD,
    3. Cooper BT,
    4. Bennett MB,
    5. Brown SE

    . Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols. Int J Environ Res Public Health 2014;11(11):11325–11347.

    OpenUrlCrossRefPubMed
53. 53.↵
    1. Flouris AD,
    2. Chorti MS,
    3. Poulianiti KP,
    4. et al

    . Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 2013;25(2):91–101.

    OpenUrlCrossRefPubMed
54. 54.↵
    1. Vardavas CI,
    2. Anagnostopoulos N,
    3. Kougias M,
    4. Evangelopoulou V,
    5. Connolly GN,
    6. Behrakis PK

    . Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012;141(6):1400–1406.

    OpenUrlCrossRefPubMedWeb of Science
55. 55.↵
    1. Ferrari M,
    2. Zanasi A,
    3. Nardi E,
    4. et al

    . Short-term effects of a nicotine-free e-cigarette compared to a traditional cigarette in smokers and non-smokers. BMC Pulm Med 2015;15:120.

    OpenUrlCrossRefPubMed
56. 56.↵
    1. Marini S,
    2. Buonanno G,
    3. Stabile L,
    4. Ficco G

    . Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide. Toxicol Appl Pharmacol 2014;278(1):9–15.

    OpenUrlCrossRefPubMed
57. 57.↵
    1. Mahapatra SK,
    2. Bhattacharjee S,
    3. Chakraborty SP,
    4. Majumdar S,
    5. Roy S

    . Alteration of immune functions and Th1/Th2 cytokine balance in nicotine-induced murine macrophages: immunomodulatory role of eugenol and N-acetylcysteine. Int Immunopharmacol 2011;11(4):485–495.

    OpenUrlPubMed
58. 58.↵
    1. Matsunaga K,
    2. Klein TW,
    3. Friedman H,
    4. Yamamoto Y

    . Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol 2001;167(11):6518.

    OpenUrlAbstract/FREE Full Text
59. 59.↵
    1. Sussan TE,
    2. Gajghate S,
    3. Thimmulappa RK,
    4. et al

    . Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS One. 2015;10(2):e0116861.

    OpenUrlCrossRefPubMed
60. 60.↵
    1. Kandra KL,
    2. Ranney LM,
    3. Lee JG,
    4. Goldstein AO

    . Physicians' attitudes and use of e-cigarettes as cessation devices, North Carolina, 2013. PLoS One 2014;9(7):e103462.

    OpenUrlCrossRefPubMed
61. 61.↵
    1. Berg CJ,
    2. Haardoerfer R,
    3. Escoffery C,
    4. Zheng P,
    5. Kegler M

    . Cigarette users' interest in using or switching to electronic nicotine delivery systems for smokeless tobacco for harm reduction, cessation, or novelty: a cross-sectional survey of US adults. Nicotine Tob Res 2015;17(2):245–255.

    OpenUrlCrossRefPubMed
62. 62.↵
    1. Brown J,
    2. Beard E,
    3. Kotz D,
    4. Michie S,
    5. West R

    . Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014;109(9):1531–1540.

    OpenUrlCrossRefPubMedWeb of Science
63. 63.
    1. Siegel MB,
    2. Tanwar KL,
    3. Wood KS

    . Electronic cigarettes as a smoking-cessation: tool results from an online survey. Am J Prev Med 2011;40(4):472–475.

    OpenUrlCrossRefPubMed
64. 64.↵
    1. Rahman MA,
    2. Hann N,
    3. Wilson A,
    4. Mnatzaganian G,
    5. Worrall-Carter L

    . E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis. PLoS One 2015;10(3):e0122544.

    OpenUrlCrossRefPubMed
65. 65.↵
    1. Caponnetto P,
    2. Cibella F,
    3. Mancuso S,
    4. Campagna D,
    5. Arcidiacono G,
    6. Polosa R

    . Effect of a nicotine free inhalator as part of a smoking cessation program. Eur Respir J. 2011;38.
66. 66.↵
    1. Bullen C,
    2. Howe C,
    3. Laugesen M,
    4. et al

    . Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013;382(9905):1629–1637.

    OpenUrlCrossRefPubMedWeb of Science
67. 67.↵
    1. Adriaens K,
    2. Van Gucht D,
    3. Declerck P,
    4. Baeyens F

    . Effectiveness of the electronic cigarette: an eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res Public Health 2014;11(11):11220–11248.

    OpenUrlCrossRefPubMed
68. 68.↵
    1. Caponnetto P,
    2. Campagna D,
    3. Cibella F,
    4. et al

    . Efficiency and safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013;8(6):e66317.

    OpenUrlCrossRefPubMed
69. 69.↵
    1. Hajek P

    . Electronic cigarettes have a potential for huge public health benefit. BMC Med 2014;12:225.

    OpenUrlCrossRefPubMed
70. 70.↵
    1. Bjartveit K,
    2. Tverdal A

    . Health consequences of smoking 1-4 cigarettes per day. Tob Control 2005;14(5):315–320.

    OpenUrlAbstract/FREE Full Text
71. 71.
    1. Tverdal A,
    2. Bjartveit K

    . Health consequences of reduced daily cigarette consumption. Tob Control 2006;15(6):472–480.

    OpenUrlAbstract/FREE Full Text
72. 72.↵
    1. Godtfredsen NS,
    2. Holst C,
    3. Prescott E,
    4. Vestbo J,
    5. Osler M

    . Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from the Copenhagen Centre for Prospective Population Studies. Am J Epidemiol 2002;156(11):994–1001.

    OpenUrlCrossRefPubMedWeb of Science
73. 73.↵
    1. England LJ,
    2. Bunnell RE,
    3. Pechacek TF,
    4. Tong VT,
    5. McAfee TA

    . Nicotine and the developing human: a neglected element in the electronic cigarette debate. Am J Prev Med 2015;49(2):286–293.

    OpenUrlCrossRefPubMed
74. 74.↵
    1. Krishnan-Sarin S,
    2. Morean ME,
    3. Camenga DR,
    4. Cavallo DA,
    5. Kong G

    . E-cigarette use among high school and middle school adolescents in Connecticut. Nicotine Tob Res 2015;17(7):810–818.

    OpenUrlCrossRefPubMed
75. 75.↵
    1. Morean ME,
    2. Kong G,
    3. Cavallo DA,
    4. Camenga DR,
    5. Krishnan-Sarin S

    . Nicotine concentration of e-cigarettes used by adolescents. Drug Alcohol Depend 2016;167:224–227.

    OpenUrl
76. 76.↵
    1. Primack BA,
    2. Soneji S,
    3. Stoolmiller M,
    4. Fine MJ,
    5. Sargent JD

    . Progression to traditional cigarette smoking after electronic cigarette use among us adolescents and young adults. JAMA Pediatr 2015;169(11):1018–1023.

    OpenUrl
77. 77.
    1. Wills TA,
    2. Sargent JD,
    3. Gibbons FX,
    4. Pagano I,
    5. Schweitzer R

    . E-cigarette use is differentially related to smoking onset among lower risk adolescents. Tob Control. 2016.
78. 78.↵
    1. Soneji S,
    2. Barrington-Trimis JL,
    3. Wills TA,
    4. et al

    . Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr. 2017;171(8):788–797.

    OpenUrl
79. 79.↵
    1. Leventhal AM,
    2. Stone MD,
    3. Andrabi N,
    4. et al

    . Association of e-cigarette vaping and progression to heavier patterns of cigarette smoking. JAMA 2016;316(18):1918–1920.

    OpenUrlPubMed
80. 80.↵
    1. Miech RA,
    2. O'Malley PM,
    3. Johnston LD,
    4. Patrick ME

    . E-cigarettes and the drug use patterns of adolescents. Nicotine Tob Res 2016;18(5):654–659.

    OpenUrlCrossRefPubMed
81. 81.↵
    1. Chen C,
    2. Zhuang YL,
    3. Zhu SH

    . E-cigarette design preference and smoking cessation: a U.S. population study. Am J Prev Med 2016;51(3):356–363.

    OpenUrlCrossRefPubMed
82. 82.
    Centers for Disease Controls. Electronic cigarettes: what's the bottom line? Available at: https://upload.wikimedia.org/wikipedia/commons/6/61/Electronic_Cigarettes%2C_What_is_the_bottom_line_CDC.pdf. Accessed July 1, 2018.